retatrutide clinical trial texas What Are the New Weight Loss Medications? VisualAbstract: Retatrutide reduces body weight

To contextualize those numbers, the researchers say this is on par with 20 years of aging-related muscle loss in adults 30 and older, who lose an estimated 3% to 5% of muscle mass per decade

For this market, In July 2025, Medtronic, a global leader in medical technology, invested $50M in the India Diabetes Center

GLP-3-style analogues (a shorthand used in some research catalogs for multi-incretin designs related to GLP-1/GIP/GCGR pharmacology) are evaluated for how combined signaling can influence downstream nodes such as insulin and glucagon dynamics, adipose tissue lipolysis, mitochondrial substrate choice, and central appetite pathways

Selective optogenetic activation of arcuate kisspeptin neurons generates pulsatile luteinizing hormone secretion